Jim Cramer Predicts Ingredion's Dominance After Tate & Lyle Acquisition
Finance

Jim Cramer Predicts Ingredion's Dominance After Tate & Lyle Acquisition

authorBy Lisa Jing
DateJun 20, 2026
Read time2 min
Renowned financial commentator Jim Cramer recently turned his attention to Ingredion Incorporated (NYSE:INGR) on his program "Mad Money," urging investors to look beyond past performance and focus on future trajectory. Cramer specifically pointed to Ingredion's significant acquisition of Tate & Lyle as a pivotal moment for the company, poised to redefine its standing within the industry.

A Strategic Acquisition to Reshape the Food Ingredients Landscape

Ingredion's Bold Move: Acquiring Tate & Lyle

Cramer delved into Ingredion's recent announcement regarding its plan to acquire the esteemed British ingredients firm, Tate & Lyle, for approximately $3.6 billion in cash. This substantial transaction, particularly for a company with a market capitalization of $6.2 billion, signals a transformative period for Ingredion.

Market Reaction Versus Long-Term Vision

Despite the market's somewhat subdued initial response to the news, Cramer firmly believes this is a misjudgment. He argues that this acquisition is set to forge an unparalleled powerhouse in the food and beverage ingredients sector, positioning Ingredion as a dominant and indispensable player.

Understanding Ingredion's Core Business

Ingredion Incorporated specializes in converting corn and other starches into essential sweeteners, starches, and advanced biomaterial solutions. The company's diverse product portfolio caters to a wide range of needs within the food and beverage industry.

Beyond the Current Headlines: Future Prospects

While acknowledging Ingredion's investment potential, other lucrative opportunities exist, particularly within the artificial intelligence sector. These specific AI stocks are believed to offer substantial growth potential with reduced risk, especially in the context of emerging market trends and trade policies.

Navigating Investment Choices in a Dynamic Market

The financial landscape is constantly evolving, presenting investors with numerous choices. While traditional industries offer stability, high-growth sectors like AI promise significant returns. It is crucial for investors to carefully evaluate all available information and consider their investment goals before making decisions.

More Articles
Finance
XBI: A "Hidden" ETF Up +70% In 1 Year
The State Street SPDR S&P Biotech ETF (XBI) has achieved over 75% performance in one year, driven by its equal-weight exposure to volatile small- and mid-cap biotech stocks. While this high beta profile offers significant upside during bullish healthcare cycles, it also carries an elevated annualized volatility of approximately 26%. Current valuations for XBI are considered stretched, with a forward P/E of 17x and earnings growth expectations below 3%, making new entries less appealing.
By Robert KiyosakiJun 20, 2026
Finance
Cramer's View on Clover Health, UnitedHealth, and CVS
Jim Cramer evaluated Clover Health as a speculative yet profitable pick, acknowledging its Q1 2026 GAAP profitability. However, he reaffirmed his preference for established healthcare giants UnitedHealth and CVS for long-term investment, emphasizing their consistent performance. Cramer advised investors to prioritize a stock's future trajectory over its past performance, even while recognizing the short-term success of speculative plays like Clover Health.
By Nouriel RoubiniJun 20, 2026
Finance
Jim Cramer's Endorsement of Vistra: A "Steal" at Current Valuations
Financial commentator Jim Cramer has offered a positive outlook on Vistra Corp. (VST), an integrated energy provider, suggesting its recent stock decline presents a buying opportunity. Despite acknowledging its previous high valuation, Cramer now views Vistra as undervalued, citing its strong earnings growth and significant role in power generation, particularly with its nuclear assets and connection to the booming data center industry.
By Michele FerreroJun 20, 2026
Finance
Jim Cramer Praises SLB's Digital Business and Future Prospects
Financial analyst Jim Cramer recently lauded SLB (formerly Schlumberger) for its innovative digital business during a 'Mad Money' segment. Despite market fluctuations, Cramer highlighted SLB's cutting-edge technology in oil and gas and its potential for growth, suggesting investors focus on future trajectory over past performance.
By Robert KiyosakiJun 20, 2026
Finance
Jim Cramer Advocates for Bank Consolidations, Commends Banco Santander's Strategic Moves
Financial analyst Jim Cramer recently emphasized the importance of bank mergers, suggesting the U.S. financial landscape has an excess of banking institutions. He lauded Banco Santander's acquisition of Webster Financial, viewing it as a shrewd move capitalizing on relaxed regulatory conditions. Cramer also offered investment advice on Santander shares, recommending a purchase if the price dips to $10. He highlighted the bank's comprehensive services, including lending, wealth management, payments, and digital banking.
By Robert KiyosakiJun 20, 2026